PrepSolution

Nursing · Study journal

FNP Mental Health Practice Questions: Depression, Anxiety and Screening

Thirteen original FNP mental health questions on USPSTF depression, anxiety, alcohol, drug and tobacco screening, PHQ-9 scoring, and bupropion contraindications, each keyed to a named source.

By Elena R.Published Reviewed by PrepSolution Editorial Team10 min read
Inside this articleNursing
Section preview 01

Depression and suicide risk

Which adults does USPSTF recommend screening for depression?

Read this section
On this page

Mental health items on the FNP boards are mostly screening and first decisions: which population gets screened, how to read a score, which drug is ruled out by a history. The answers come from USPSTF recommendations, the validation data for the screening tools, and drug labels.

This set is built for candidates using FNP-C exam prep. Assess is the largest practice domain on the NPCB blueprint at 32% of scored items, and screening questions sit there. The AANP FNP exam blueprint guide explains the rest of the weighting. Adolescent depression screening is in our pediatrics set, and antidepressant boxed warnings are in the pharmacology set, so neither is repeated here.

This set is exam practice written from the guidelines, USPSTF recommendations and FDA labels listed under References. The questions are original PrepSolution items, not NPCB or ANCC exam questions. It is not clinical guidance for any patient, and it has not been reviewed by a credentialed nurse practitioner.

Depression and suicide risk

Question 1: Who to screen for depression

Which adults does USPSTF recommend screening for depression?

  • A. Only adults with a prior episode
  • B. Only adults under 65
  • C. Only postpartum persons
  • D. All adults, including pregnant and postpartum persons and older adults

Best answer: D. USPSTF recommends screening for depression in the adult population, including pregnant and postpartum persons and older adults, regardless of risk factors. Grade B.

  • A is not the best answer. Screening is not limited to people with a history; USPSTF recommends it regardless of risk factors.
  • B is not the best answer. Older adults are included.
  • C is not the best answer. Pregnant and postpartum persons are included, but so is everyone else.

Question 2: Screening for suicide risk

What is the USPSTF position on screening the general adult population for suicide risk in primary care?

  • A. Screen all adults annually (Grade A)
  • B. Insufficient evidence to weigh benefits and harms (I statement)
  • C. Recommend against screening (Grade D)
  • D. Screen only adults over 65 (Grade B)

Best answer: B. USPSTF concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons and older adults. This is separate from the B recommendation to screen for depression.

  • A is not the best answer. USPSTF does not give suicide risk screening an A grade.
  • C is not the best answer. An I statement is neither a recommendation for screening nor one against it.
  • D is not the best answer. The I statement covers all adults, including older adults.

Question 3: Reading a PHQ-9 score

A 31-year-old scores 16 on the PHQ-9. Using the severity cut points from the original validation study, how is this classified?

  • A. Mild
  • B. Moderate
  • C. Moderately severe
  • D. Severe

Best answer: C. In the validation study by Kroenke and colleagues, PHQ-9 scores of 5, 10, 15 and 20 represented mild, moderate, moderately severe and severe depression. A score of 16 is at or above 15 and below 20.

  • A is not the best answer. Mild begins at 5.
  • B is not the best answer. Moderate begins at 10 and ends below 15.
  • D is not the best answer. Severe begins at 20.

Question 4: What a PHQ-9 of 10 means

In the PHQ-9 validation study, how did a score of 10 or more perform against a mental health professional interview for major depression?

  • A. Sensitivity 88% and specificity 88%
  • B. Sensitivity 50% and specificity 95%
  • C. It confirmed the diagnosis without interview
  • D. It had no diagnostic value

Best answer: A. Using the mental health professional reinterview as the criterion standard, a PHQ-9 score of 10 or more had a sensitivity of 88% and a specificity of 88% for major depression. A positive screen still needs further evaluation, which matches the USPSTF note that people who screen positive should be evaluated for diagnosis.

  • B is not the best answer. These figures do not match the study.
  • C is not the best answer. A screening score does not by itself confirm a diagnosis.
  • D is not the best answer. The study found useful accuracy at this cut point.

Question 5: Screening tool after delivery

Which depression screening instrument does the USPSTF recommendation name for postpartum and pregnant persons?

  • A. Geriatric Depression Scale
  • B. Edinburgh Postnatal Depression Scale (EPDS)
  • C. GAD-7
  • D. AUDIT-C

Best answer: B. USPSTF lists commonly used depression instruments: the PHQ in various forms for adults, the CES-D, the Geriatric Depression Scale in older adults, and the Edinburgh Postnatal Depression Scale in postpartum and pregnant persons.

  • A is not the best answer. The Geriatric Depression Scale is named for older adults.
  • C is not the best answer. The GAD-7 is an anxiety tool.
  • D is not the best answer. The AUDIT-C screens for unhealthy alcohol use.

Anxiety

Question 6: Anxiety screening in younger adults

A 42-year-old has no known mental health history. What does USPSTF recommend about anxiety screening?

  • A. Screen for anxiety disorders (Grade B)
  • B. Screen only if she reports panic attacks
  • C. Evidence is insufficient (I statement)
  • D. Recommend against screening (Grade D)

Best answer: A. USPSTF recommends screening for anxiety disorders in adults 64 or younger, including pregnant and postpartum persons. Grade B.

  • B is not the best answer. The recommendation does not depend on symptoms.
  • C is not the best answer. The I statement applies to adults 65 and older.
  • D is not the best answer. USPSTF does not recommend against anxiety screening.

Question 7: Anxiety screening after 65

What is the USPSTF position on screening a 70-year-old without symptoms for anxiety disorders?

  • A. Screen annually (Grade B)
  • B. Recommend against (Grade D)
  • C. Insufficient evidence to weigh benefits and harms (I statement)
  • D. Screen only if depression screening is positive

Best answer: C. For adults 65 and older, USPSTF concludes that evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders.

  • A is not the best answer. The B recommendation covers adults 64 and younger.
  • B is not the best answer. It is not a recommendation against screening.
  • D is not the best answer. USPSTF does not link anxiety screening in older adults to depression results.

Question 8: Anxiety screening tools

Which instruments does the USPSTF evidence review name as the most commonly studied for anxiety screening?

  • A. PHQ-9 and CES-D
  • B. AUDIT-C and SASQ
  • C. EPDS and Geriatric Depression Scale
  • D. GAD-2 and GAD-7

Best answer: D. USPSTF reports that the GAD-2 and GAD-7 were the most commonly studied instruments and showed adequate sensitivity and specificity to detect generalized anxiety disorder.

  • A is not the best answer. The PHQ-9 and CES-D are depression instruments.
  • B is not the best answer. The AUDIT-C and SASQ screen for unhealthy alcohol use.
  • C is not the best answer. The EPDS and Geriatric Depression Scale are depression instruments.

Alcohol, drugs and tobacco

Question 9: Alcohol screening tools

Which approach does USPSTF describe as having the best accuracy for screening adults for unhealthy alcohol use?

  • A. Serum gamma-glutamyl transferase
  • B. A breath alcohol test at each visit
  • C. Liver ultrasound
  • D. One- to 3-item instruments such as the AUDIT-C or the single alcohol screening question

Best answer: D. USPSTF recommends screening adults 18 and older for unhealthy alcohol use (B) and states that 1- to 3-item instruments, including the AUDIT-C and the NIAAA single alcohol screening question, have the best accuracy.

  • A is not the best answer. Laboratory markers are not the screening approach USPSTF describes.
  • B is not the best answer. USPSTF screening uses questions, not breath testing.
  • C is not the best answer. Imaging is not a screening approach for unhealthy alcohol use.

Question 10: Alcohol screening in a teenager

What does USPSTF conclude about screening and brief counseling for alcohol use in primary care for adolescents aged 12 to 17?

  • A. Insufficient evidence to weigh benefits and harms (I statement)
  • B. Screen all adolescents annually (Grade B)
  • C. Recommend against screening (Grade D)
  • D. Screen only those who drive

Best answer: A. USPSTF concludes that current evidence is insufficient to assess the balance of benefits and harms of screening and brief behavioral counseling for alcohol use in primary care for adolescents aged 12 to 17. The B recommendation applies to adults 18 and older.

  • B is not the best answer. The B grade applies to adults, not adolescents.
  • C is not the best answer. It is not a recommendation against screening.
  • D is not the best answer. Driving status is not part of the statement.

Question 11: What drug use screening means

USPSTF recommends screening adults 18 and older for unhealthy drug use. What does "screening" mean in this recommendation?

  • A. A urine drug test at every visit
  • B. Asking questions about unhealthy drug use, not testing biological specimens
  • C. A hair sample once a year
  • D. Testing only patients prescribed opioids

Best answer: B. USPSTF recommends screening by asking questions about unhealthy drug use in adults 18 and older (B), and states that screening refers to asking questions, not testing biological specimens. Screening should be done when services for diagnosis, treatment and care can be offered or referred.

  • A is not the best answer. The recommendation explicitly excludes specimen testing from its meaning of screening.
  • C is not the best answer. Hair testing is specimen testing, which the recommendation does not mean.
  • D is not the best answer. The recommendation covers adults generally, not only patients on opioids.

Question 12: Bupropion contraindications

A 22-year-old with depression wants bupropion because she worries about weight gain. She has a history of bulimia nervosa. What does the Wellbutrin XL label say?

  • A. Bupropion is preferred because it avoids weight gain
  • B. Bupropion is safe if the eating disorder is in remission
  • C. Use half the usual dose
  • D. Current or prior bulimia or anorexia nervosa is a contraindication

Best answer: D. The Wellbutrin XL label lists seizure disorder and a current or prior diagnosis of bulimia or anorexia nervosa as contraindications, along with abrupt discontinuation of alcohol, benzodiazepines, barbiturates or antiepileptic drugs.

  • A is not the best answer. Her history makes bupropion contraindicated regardless of weight goals.
  • B is not the best answer. The contraindication covers a prior diagnosis, not only active illness.
  • C is not the best answer. Dose reduction does not remove a contraindication.

Question 13: Quitting smoking in pregnancy

A 27-year-old who is 10 weeks pregnant smokes and wants to quit. What does USPSTF recommend?

  • A. Start varenicline at once
  • B. Recommend e-cigarettes as a safer step
  • C. Provide behavioral interventions for cessation; evidence on pharmacotherapy in pregnancy is insufficient
  • D. Advise cutting down only, since quitting is stressful

Best answer: C. USPSTF recommends asking all pregnant persons about tobacco use, advising them to stop, and providing behavioral interventions (Grade A). It finds the evidence insufficient on pharmacotherapy for cessation in pregnancy (I).

  • A is not the best answer. Evidence on pharmacotherapy in pregnancy is insufficient; behavioral intervention is the recommended step.
  • B is not the best answer. USPSTF found the evidence insufficient on e-cigarettes for cessation, including in pregnancy.
  • D is not the best answer. USPSTF recommends advising pregnant persons to stop using tobacco.

Screening grades in this set

TopicPopulationGrade
Depression screeningAll adults, including pregnant, postpartum and older adultsB
Suicide risk screeningAll adultsI
Anxiety screeningAdults 64 and younger, including pregnant and postpartumB
Anxiety screeningAdults 65 and olderI
Unhealthy alcohol useAdults 18 and olderB
Alcohol useAdolescents 12 to 17I
Unhealthy drug use, by asking questionsAdults 18 and olderB
Tobacco cessation, behavioralPregnant personsA
Tobacco cessation, pharmacotherapyPregnant personsI
USPSTF recommendations used above. B recommends the service; I means the evidence is insufficient.

How should you use this set?

Most of these items turn on the population in the stem. Read the age and pregnancy status before anything else, then match the grade. For score questions, write out the PHQ-9 bands (5, 10, 15, 20) until you can recall them without looking. For a drug question, check the history in the stem against the label contraindications before thinking about benefits.

For timed questions across every domain and age group on the blueprint, see FNP-C exam prep.

Elena R.

PrepSolution Content Editor, Nurse Practitioner Certification

About PrepSolution

References

  1. [1] USPSTF (2023). Depression and Suicide Risk in Adults: Screening. USPSTF. USPSTF
  2. [2] USPSTF (2023). Anxiety Disorders in Adults: Screening. USPSTF. USPSTF
  3. [3] USPSTF (2018). Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions. USPSTF. USPSTF
  4. [4] USPSTF (2020). Unhealthy Drug Use: Screening. USPSTF. USPSTF
  5. [5] USPSTF (2021). Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions. USPSTF. USPSTF
  6. [6] Kroenke K, Spitzer RL, Williams JB (2001). The PHQ-9: Validity of a Brief Depression Severity Measure (J Gen Intern Med). Kroenke K, Spitzer RL, Williams JB. Kroenke K, Spitzer RL, Williams JB
  7. [7] FDA label (2026). Wellbutrin XL (bupropion hydrochloride extended-release). FDA label. FDA label
  8. [8] NPCB (2026). FNP Candidate Handbook (June 2026). NPCB. NPCB

Help us improve this guide

How helpful was this article?

One tap helps us understand what’s useful.

Not helpful → Very helpful

Frequently asked questions

Yes. It recommends screening all adults, including pregnant and postpartum persons and older adults (Grade B).

No. It found the evidence insufficient to assess the benefits and harms of screening adults for suicide risk (I statement).

In the original validation study, scores of 5, 10, 15 and 20 represented mild, moderate, moderately severe and severe depression.

USPSTF recommends screening adults 64 and younger, including pregnant and postpartum persons (Grade B). Evidence for adults 65 and older is insufficient.

The label lists seizure disorder, current or prior bulimia or anorexia nervosa, abrupt discontinuation of alcohol, benzodiazepines, barbiturates or antiepileptic drugs, and use with MAOIs.

No. They are original PrepSolution items written from the sources listed under References. They are not clinical guidance and have not been reviewed by a credentialed nurse practitioner.

Keep practicing for the FNP-C.

Review the study tools, access options and price, or start with free practice.

Related Articles